logo-loader

Seelos Therapeutics

Receive alerts
Market:
NASDAQ
Market Cap:
$19.4 m
Price
0.72 USD
Change
-9.46%
52 weeks high
10.44
52 weeks low
0.72

In brief

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company’s robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.

 

 

Deep dive We explore the investor case for growth companies

Snapshot

The New York clinical-stage biopharmaceutical company has several drugs in the pipeline capable of generating hefty revenue